Table 1 Association between different patient and cancer-specific variables with CRP elevation prior to penile cancer surgery
From: High CRP values predict poor survival in patients with penile cancer
Variable | CRP ≤ 15 mg/l | CRP > 15 mg/l | p-value |
|---|---|---|---|
Age, median [years] (IQR)1 | 64.8 (58-71) | 70.3 (62-77) | 0.07 |
BMI, median [kg/m2] (IQR)1 | 26.6 (24.1-29.4) | 26.1 (21.9-28.3) | 0.19 |
Stage | 0.012 | ||
pTis | 11 (18.3%) | 1 (5.3%) | |
pTa | 3 (5.0%) | 1 (5.3%) | |
pT1 | 24 (40.0%) | 3 (15.8%) | |
pT2 | 17 (28.3%) | 6 (31.6%) | |
pT3 | 4 (6.7%) | 5 (26.3%) | |
pT4 | 1 (1.7%) | 3 (15.8%) | |
Nodal metastasis1 | 0.007 | ||
N0 | 41 (83.7%) | 7 (46.7%) | |
N+ | 8 (16.3%) | 8 (53.3%) | |
Grade | 0.53 | ||
G1 | 11 (22.9%) | 2 (11.1%) | |
G2 | 25 (52.1%) | 10 (55.6%) | |
G3/4 | 12 (25.0%) | 6 (33.3%) |